Cagan McAfee Capital Partners Teams with Myles Sherman

Objective
Post date: August 16, 2017

Share This Post

Objective Capital Partners Acted as Financial Advisor to MID

San Diego, CA- August 21, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Minimally Invasive Devices (MID), privately-held medical device and market leading laparoscopic surgery solutions company, upon its acquisition by Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX. Objective Capital Partners acted as financial advisors to MID.

Minimally Invasive Devices (MID), founded in 2006, developed a patented disposable laparoscopic sheath technology which substantially improves visual clarity, substantially decreases interruptions to remove and clean the scope, and protects scope optics from becoming dirty, thus making clear, continuous vision a new standard for laparoscopic procedures. MID has positioned its products in two classes in the form of its commercialized products: FloShield™ Air and FloShield™ Plus. The products are FDA and CE approved and have been sold throughout the US, Europe, Australia and parts of Asia.

Laird Cagan, will be Chairman/CEO and Myles Sherman will be a hands-on board member. MID founder, Dr. Wayne Poll, will continue with the new company to be called FloShield, Inc. Financial terms of the deal were not disclosed.

About Cagan McAfee Capital Partners

Cagan McAfee Capital Partners, LLC (CMCP) is an established Silicon Valley-based private investment firm with a proven track record of being able to maximize the potential of high growth companies. When companies are at a strategic inflection point, having completed the initial development of their product and demonstrated clear market acceptance, we step in to provide the expansion stage venture capital and growth capital needed to help these companies reach their long-term goals. More information on CMCP can be found at http://www.cmcp.com/.

About FloShield, Inc. (formerly MID)

FloShield, Inc. develops laparoscopic visualization systems. It offers FloShield Air, which includes Vortex Barrier Technology that provides a continuous flow of dry carbon dioxide gas over the tip of the scope, instantly defogging it while continuously shielding it from condensation, debris, and smoke. The company also offers FloShield Plus that includes Vortex Barrier Technology, as well as Flo-X in situ, an intra-operative flush that can be used to clean a scope if it gets dirty during surgery. Its products are used in various surgical procedures, including general surgery, gynecology, oncology, bariatric, urology, cardio/thoracic, and transplantation. Minimally Invasive Devices, Inc. was incorporated in 2006 and is based in Columbus, Ohio. More information on MID can be found at http://floshield.com/.

About Objective Capital Partners

Objective Capital Partners is a leading M&A investment banking firm whose Principals have collectively engaged in more than 500 successful transactions serving the transaction needs of growth stage and mid-size companies. The executive team has a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to companies. The firm focuses on middle market M&A and capital raise activities for companies with enterprise values between $10-100 million, healthcare & life sciences and valuation advisory services. The firm’s industry expertise includes software and hardware technology, life sciences, business services, IT services, healthcare services, biotech, consumer products and specialized manufacturing. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. The Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities. Additional information on Objective Capital Partners is available at www.objectiveibv.com.

Disclosure

This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.